| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
3
2
5
5
2
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
A-
(Buy)
|
Fund Holdings
The fund is overweight in healthcare companies with nearly twice the allocation of similar funds. As of Sept. 30, 2010, about 55 percent of its holdings were considered mid-cap stocks. Much of the rest of its portfolio consisted of newer additions of small-cap stocks. The fund did not own any media or telecom companies in the third quarter of 2010.
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 3.96 | 0.02 | 3.94 |
| Stocks | 88.95 | 0.0 | 88.95 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.54 | 0.0 | 0.54 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 6.58 | 0.0 | 6.58 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 12.31.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 12.31.2012
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Church & Dwight Company, Inc. | CHD | 17.94 | 2.76 |
| Compass Minerals International, Inc. | CMP | 14.52 | 2.16 |
| AptarGroup, Inc. | ATR | 17.29 | 2.09 |
| Westinghouse Air Brake Technologies Corp | WAB | 17.31 | 1.97 |
| Solera Holdings, Inc. | SLH | 6.74 | 1.89 |
| Clarcor Inc. | CLC | 5.88 | 1.86 |
| Haemonetics Corporation | HAE | -7.57 | 1.75 |
| Oceaneering International | OII | 29.39 | 1.72 |
| Polaris Industries, Inc. | PII | -0.19 | 1.69 |
| Idexx Laboratories | IDXX | -8.15 | 1.63 |
